“There is no doubt that we should do genomic tests as early as possible. When we come in very early, we know that we can actually change the course of disease for the patient,” says Professor Finn Cilius Nielsen, M.D., Head of the Center for Genomic Medicine at Rigshospitalet in Copenhagen, Denmark.

Using NGS technology, Center for Genomic Medicine at Rigshospitalet sequenced the DNA of a lung cancer patient and identified a BRAF activating mutation. The team at Rigshospitalet predicted that the patient would benefit from a treatment targeted at this specific mutation – even though, normally only patients with a melanoma would receive this drug. The patient responded very well and the mutation is no longer detected in the free circulating DNA. The patient is still alive today.

Read the full interview

When clinical lab Aeon Global Health entered the hereditary testing market, they knew that automation was critical to success. Genomics software was faster than human experts—and more cost-effective.

Listen to our round-table discussion to discover how Aeon selected a genomics solution. Gain valuable insights to build on Aeon’s experience and accelerate your own path to success.

Join speakers Dr. Shawn Desai, Chief Technology Officer of Aeon Global Health, Dr. Ramon Felciano, Chief Technology Officer and Vice President of Strategy of QIAGEN Bioinformatics, and Kristina Kermanshahche, Global Director of Life Sciences at Intel Corporation, as they discuss how Aeon selected this powerful genomics solution and how you can build upon Aeon’s experience and accelerate your own path to success.

Read the blog

Center for Genomic Medicine is transforming advances in genomics into better diagnostics and treatments for patients. The Center facilitates the knowledge about genomic medicine in clinical care and in close collaboration with the Phase 1 unit at Rigshospitalet, they are employing next-generation sequencing to improve treatment and survival.

Read the blog “Advancing the Pace of NGS: Accelerating the deployment of precision medicine capabilities” to learn more.

Mikael Flensborg of Qiagen Bioinformatics and Kristina Kermanshahche of Intel share how different configurations of the Intel® Scalable System Framework help optimize genome sequencing performance and workflows.

Life sciences and technology are coming together to revolutionize scientific and medical discovery from human genome sequencing to worldwide healthcare collaboration. Focus on industry collaborations with BioTeam, QIAGEN, Aspera, GenoSpace, & Biological Dynamics.

Spurred by NGS technologies, more genomic data is generated today than in the entire history of mankind before. Advanced bioinformatics tools help to analyze and interpret these vast amounts of data to generate valuable insights.

Hear from Professor Madhuri Hegde, Ph.D., Professor of Human Genetics and Executive Director of the Emory Genetics Lab, Emory University School of Medicine, who developed one of the earliest clinical genomics programs starting in 2009.

Ramon Felciano, CTO and VP, Technology & Strategy, Founder, Ingenuity Systems, Inc., a QIAGEN company, describes the role of QIAGEN Clinical Insights in combining critical variant and related molecular profile information, with the latest curated scientific findings, to produce actionable clinical reports, incorporating both diagnosis and clinical guidance so essential to precision medicine.